Kanceftri TZ 500mg/62.50mg Injection
By Kanceftri TZ
Rx
1 Injection in a Vial

Composition
Ceftriaxone(500mg) + Tazobactum(62.50mg)

Manufacturer - Fortune Life Sciences Private Limited
J-2/S-1, VIJAY PARK CO-OP. HSG. SOCIETY, DIAS AND PEREIRA NAGAR, NAIGAON (W) THANE Thane MH 401207 IN

Expires on or after
October, 2025

liver
When using Kanceftri TZ 500mg/62.50mg Injection, it's important to be cautious if you have severe liver disease. In such cases, your doctor may need to adjust the dose of the injection to ensure it is safe and effective for you. It is important to consult your doctor before starting treatment with Kanceftri TZ 500mg/62.50mg Injection if you have severe liver disease. However, for patients with mild to moderate liver disease, dose adjustment of Kanceftri TZ 500mg/62.50mg Injection is not usually necessary. If you have any concerns about how this injection may affect your liver, make sure to talk to your doctor for personalized guidance.

kidney
Limited information exists on using Kanceftri TZ 500mg/62.50mg Injection in kidney disease patients. Please consult your doctor.

alcohol
When using Kanceftri TZ 500mg/62.50mg Injection, it is safe to consume alcohol without causing harmful side effects. However, caution should be taken during pregnancy.

driving
Kanceftri TZ 500mg/62.50mg Injection can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these side effects.

pregnancy
Kanceftri TZ 500mg/62.50mg Injection is generally safe during pregnancy based on animal studies, showing minimal adverse effects on the baby. Limited human studies are available.

breastfeeding
Caution should be taken when using Kanceftri TZ 500mg/62.50mg Injection during breastfeeding. It is advised to stop breastfeeding until the mother's treatment is finished and the drug is cleared from her body.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹91
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024